Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$50.01 - $73.35 $870,974 - $1.28 Million
-17,416 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$59.21 - $78.66 $15,986 - $21,238
-270 Reduced 1.53%
17,416 $1.13 Million
Q2 2021

Jul 12, 2021

BUY
$51.39 - $66.9 $24,153 - $31,443
470 Added 2.73%
17,686 $1.12 Million
Q1 2021

May 13, 2021

BUY
$49.14 - $59.89 $845,994 - $1.03 Million
17,216 New
17,216 $1.03 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.